Astellas Pharma Aktie - YPH

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

8,208

Gebot

8,13

Fragen

8,294

Volumen

8,114 Tagesbereich 8,332

7,68 52-Wochen-Bereich 12,00

Handelsende

8,168

Handelsbeginn

8,114

Letzte Trade

8.332

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

975

Finanzvolumen

VWAP

Takeda, Astellas and Sumitomo to create new drug discovery company

Takeda Pharmaceutical Co Ltd, Astellas Pharma Inc and Sumitomo Mitsui Financial Group Inc on Monday agreed to establi ...

IN BRIEF: Astellas receives FDA exclusivity approval for Cresemba

nc - Tokyo-based pharmaceutical company - Receives orphan drug and pediatric exclusivity approval from the US Food & D ...

*Astellas: FDA grants drug exclusivity to Cresemba aspergillosis, mucormycosis treatment

...

Merck and Astellas drugs get priority review in US and Japan

Merck & Co Inc announced on Tuesday that its cancer treatment Keytruda with chemotherapy has been granted priority re ...

Astellas and Pfizer's Padcev validated by EMA to treat bladder cancer

Pfizer Inc and Astellas Pharma Inc on Friday celebrated the European Medicines Agency's decision to validate its appl ...

Astellas, Merck, Pfizer celebrate US approval for Keytruda plus Padcev

Astellas Pharma Inc, Merck & Co Inc and Pfizer Inc on Friday announced expanded approval in the US for Keytruda combi ...

IN BRIEF: Astellas Pharma announces US FDA green light for Cresemba

nc - Tokyo-based pharmaceutical company - Says the US Food & Drug Administration has approved Cresemba, an azole antif ...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0.052	0.637567435017	8.156	8.378	7.68	1168	7.99235445	DE
4	-1.16	-12.3825789923	9.368	9.4	7.68	774	8.33314942	DE
12	-0.794	-8.82026216396	9.002	9.702	7.68	975	9.02255976	DE
26	-2.427	-22.8208744711	10.635	12	7.68	1192	9.53398594	DE
52	-0.69	-7.75455158463	8.898	12	7.68	1492	9.72818712	DE
156	-5.857	-41.6423746889	14.065	14.4	7.68	1496	10.11401707	DE
260	-5.857	-41.6423746889	14.065	14.4	7.68	1496	10.11401707	DE

YPH - Frequently Asked Questions (FAQ)

What is the current Astellas Pharma share price?

The current share price of Astellas Pharma is 8,208 €

What is the 1 year trading range for Astellas Pharma share price?

Astellas Pharma has traded in the range of 7,68 € to 12,00 € during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
AZK0Hertz Global Holdings Inc	7,27 € (45,40%)	366,15k
601AAmmPower Corp	0,0215 € (43,33%)	18,51k
DPMSumitomo Pharma Co. Ltd.	4,50 € (43,31%)	7,6k
UQ1Uniqure NV	11,25 € (36,26%)	7,73k
F1BLhyfe SA	4,225 € (35,42%)	282
KASHIntellabridge Technology Corp	0,0155 € (-35,42%)	1,79k
A4YACCENTRO Real Estate AG	0,088 € (-31,78%)	5,2k
IAHInternational Lithium Corp	0,0085 € (-26,09%)	102,38k
VJ3Troy Minerals Inc	0,0635 € (-23,49%)	21,01k
OYM1Odyssey Marine Exploration Inc	0,474 € (-22,30%)	22,79k
013CJDcom Inc	15,378 € (0,00%)	0
013AJD.com Inc	30,55 € (0,00%)	0
0110Thesis Gold Inc	0,606 € (0,00%)	0
00WAspermont Ltd	0,0025 € (0,00%)	0
000Greenvolt Energias Renovaveis SA	0,00 € (0,00%)	0

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Astellas Pharma Inc (YPH)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

YPH Neueste Nachrichten

Takeda, Astellas and Sumitomo to create new drug discovery company

IN BRIEF: Astellas receives FDA exclusivity approval for Cresemba

*Astellas: FDA grants drug exclusivity to Cresemba aspergillosis, mucormycosis treatment

Merck and Astellas drugs get priority review in US and Japan

Astellas and Pfizer's Padcev validated by EMA to treat bladder cancer

Astellas, Merck, Pfizer celebrate US approval for Keytruda plus Padcev

IN BRIEF: Astellas Pharma announces US FDA green light for Cresemba

YPH - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Astellas Pharma Inc (YPH) Börsenkurse

Astellas Pharma Inc (YPH)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

YPH Neueste Nachrichten

Takeda, Astellas and Sumitomo to create new drug discovery company

IN BRIEF: Astellas receives FDA exclusivity approval for Cresemba

*Astellas: FDA grants drug exclusivity to Cresemba aspergillosis, mucormycosis treatment

Merck and Astellas drugs get priority review in US and Japan

Astellas and Pfizer's Padcev validated by EMA to treat bladder cancer

Astellas, Merck, Pfizer celebrate US approval for Keytruda plus Padcev

IN BRIEF: Astellas Pharma announces US FDA green light for Cresemba

YPH - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen